Ranibizumab and Bevacizumab Equally Effective Against AMD

The drugs were equally effective in eliminating the fluid associated with neovascular AMD in a randomized controlled trial; monthly dosing was more effective than as-needed dosing.
Medscape Medical News

Full Story →